Perminova Respiratory Effort Accuracy Validation 09-12-2013-Rev 2
NCT ID: NCT02048436
Last Updated: 2014-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2013-09-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiological Effects of Continuous Negative External Pressure for Acute Hypoxemic Respiratory Failure
NCT05675345
Real World Assessment of Resistance Breathing Device
NCT07187349
Neurally Adjusted Ventilatory Assist (NAVA) in NonInvasive Ventilation (NIV)
NCT01426178
Respiration Validation for CPM Device
NCT05445492
Neurally Adjusted Ventilatory Assist (NAVA) Study in Adults With Acute Respiratory Failure
NCT01730794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A range of stable respiratory rates will be elicited from each volunteer test subject. The rates will be approximately 5, 10, 15, 20, 25, 30, 35 and 40 breaths per minute; with some natural variation from these exact numbers.
Each subject will be instrumented with an open system mask that allows for measurement of the end tidal carbon dioxide (EtCO2) respiratory rate and tidal volume. The EtCO2 monitor will be used as the Accuracy Reference Device (Reference) in this study. Performance of the currently released ECG Impedance Respiratory Rate monitor (Acceptance Standard) will be used to establish the acceptance criteria in this study by comparing to Reference.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
male female 18-45 years range of body types
18 male female subject mix that are 18-45 years of age and selected to represent a range of body types of varying physiques and body mass indexes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female
* 18-45
* range of physiques
* healthy
Exclusion Criteria
* skin inflammation
* implanted devices such as pacemakers
* pregnant
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinimark, LLC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinimark Laboratory
Louisville, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
78o944o
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.